EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.
Issue link: https://digital.eyeworld.org/i/1521228
SUMMER 2024 | EYEWORLD | 25 schedule. Since this meeting will be taught by the implant surgeons and business leaders who have mastered premium implants, coupled with the industry support for the practices attending, the response has been amazing. We are limiting this first meeting to 75 surgeons and asking that the staff person in charge of the team and implementing the patient premium implant experience also attend." This meeting will take place in September in Dallas, Texas. "I think as incoming president, you're thinking about what ways could you give something back," Dr. Thompson said. "I tell my fellow ophthalmologists that with reduced reimbursements, it helps the practice health if we're comfortable delivering advanced technol- ogies that patients are willing to invest in. For me, my comfort with delivering the patient-pay side of medicine helps to fund technology for my Medicare and Medicaid patients." Dr. Thompson finds value in this hybrid approach of having cash-pay procedures and third-party reimbursement complementing each other. He wants to help ophthalmologists who have been so dependent on third-party reimbursement to have the tools and comfort to deliver advanced technologies that patients will invest in. This will help serve their patient population who wants to learn about options as they make their lifelong vision decisions, which in the end will also help the health of the practice, he said. Dr. Thompson again stressed the honor he feels to be the next ASCRS President. "It has been a beautiful evolution for me, and I am so thankful for all those who have supported me in my journey," he said. © 2024 Primera Medical Solutions, Rosenberg, TX 77471 USA with OCuSOFT ® Lid Scrub ® PLUS Eyelid Cleanser Azithromycin Dihydrate 1% Diclofenac Sodium 0.1% & Prescription Medicated Eyelid Cleanser with Antibiotic and Anti-Inflammatory Phone, Fax or E-Scribe to our Pharmacy Today! Phone: (800) 610-2521 | Fax: (346) 321-4500 Triune Spray Custom compounded prescriptions offered by Primera Professional Pharmacy are not FDA-approved, as they have not undergone FDA premarket review for safety, effectiveness, and quality. We resolutely abide by Section 503A of the FD&C Act, and while not required to comply with cGMP requirements, we can be inspected by the FDA. Compounded medications are intended for professional use only and are not essential copies of commercially available products. Please be aware that the FDA has not reviewed any of the compounded medications we provide for safety and efficacy. Some ingredients may carry potential risks. For more information, visit our website or contact us directly. *Patent-Pending